Compagnie Lombard Odier S Cm A Vertex Pharmaceuticals Inc Transaction History

Compagnie Lombard Odier S Cm A

$6.42 Billion
Q4 2024

A detailed history of Compagnie Lombard Odier S Cm A transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Compagnie Lombard Odier S Cm A holds 9,565 shares of VRTX stock, worth $4.33 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

9,565

Previous 10,429 8.28%

Holding current value

$4.33 Million

Previous $4.85 Million 20.6%

% of portfolio

0.06%

Previous 0.08%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 30, 2025	SELL	$396.64 - $516.74 $342,696 - $446,463	-864 Reduced 8.28%	9,565 $3.85 Million
Q3 2024 Oct 11, 2024	BUY	$460.0 - $505.78 $1.47 Million - $1.62 Million	3,200 Added 44.27%	10,429 $4.85 Million
Q2 2024 Jul 18, 2024	BUY	$392.81 - $485.53 $1.15 Million - $1.42 Million	2,929 Added 68.12%	7,229 $3.39 Million
Q1 2024 May 01, 2024	BUY	$407.69 - $446.08 $1.22 Million - $1.34 Million	3,000 Added 230.77%	4,300 $1.8 Million
Q3 2023 Oct 23, 2023	SELL	$338.18 - $362.46 $202,908 - $217,476	-600 Reduced 31.58%	1,300 $452,000
Q1 2023 May 01, 2023	SELL	$283.23 - $323.1 $1.02 Million - $1.17 Million	-3,614 Reduced 65.54%	1,900 $598,000
Q4 2022 Feb 13, 2023	BUY	$285.76 - $321.48 $1.2 Million - $1.35 Million	4,214 Added 324.15%	5,514 $1.59 Million
Q3 2022 Nov 09, 2022	SELL	$273.83 - $305.53 $90,363 - $100,824	-330 Reduced 20.25%	1,300 $376,000
Q4 2021 Feb 09, 2022	BUY	$177.01 - $223.45 $221,262 - $279,312	1,250 Added 328.95%	1,630 $358,000
Q2 2021 Jul 15, 2021	BUY	$187.49 - $221.1 $24,373 - $28,743	130 Added 52.0%	380 $76,000
Q1 2021 Apr 23, 2021	BUY	$207.02 - $241.31 $51,755 - $60,327	250 New	250 $54,000
Q3 2020 Nov 12, 2020	SELL	$255.65 - $303.1 $83,086 - $98,507	-325 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$225.48 - $295.8 $16,911 - $22,185	75 Added 30.0%	325 $94,000
Q1 2020 May 13, 2020	BUY	$199.77 - $247.81 $49,942 - $61,952	250 New	250 $59,000
Q1 2019 May 13, 2019	SELL	$163.73 - $194.7 $49,119 - $58,410	-300 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$151.91 - $192.21 $30,382 - $38,442	-200 Reduced 40.0%	300 $50,000
Q2 2018 Aug 10, 2018	BUY	$145.72 - $169.96 $72,860 - $84,980	500 New	500 $85,000

Others Institutions Holding VRTX

# of Institutions

1,728

Shares Held

223M

Call Options Held

1.65M

Put Options Held

1.38M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Compagnie Lombard Odier S Cm A, based on Form 13F filings with the SEC.

News

Stay updated on Compagnie Lombard Odier S Cm A with notifications on news.

Account

Compagnie Lombard Odier S Cm A Vertex Pharmaceuticals Inc Transaction History